Defunct Company
Total Trials
9
As Lead Sponsor
6
As Collaborator
3
Total Enrollment
468
NCT02323633
Phase IIa Exploratory Clinical Trial, to Examine the Safety and Efficacy of tPCS on Paediatric ADHD Participants
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2015
Completion: Oct 31, 2015
NCT03230890
HIRREM in Military Personnel
Phase: N/A
Role: Collaborator
Start: Feb 16, 2015
Completion: Apr 5, 2021
NCT03649958
Neurotechnology Following Traumatic Brain Injury
Start: Aug 28, 2018
Completion: Jul 1, 2024
NCT04039178
Efficacy of EMF BCI Based Device on Acute Stroke
Start: Sep 4, 2018
Completion: Mar 21, 2020
NCT04050696
The Use of Electromagnetic Field (EMF) Treatment in Chronic Spinal Cord Injury (SCI) Patients
Start: Sep 18, 2019
Completion: Feb 1, 2024
NCT05044507
"The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE EMAGINE STUDY)"
Start: Dec 4, 2021
Completion: Jan 16, 2024
NCT06386874
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
Start: Aug 20, 2024
Completion: Oct 31, 2026
NCT06979466
Q Therapeutic System for Chronic Stroke Recovery
Start: May 26, 2025
Completion: Jun 30, 2026
NCT07095920
RESPARK - Brain Q for Chronic Stroke
Start: Aug 27, 2025
Completion: Dec 31, 2026